Polyethylene Glycol 3350
Excipient (pharmacologically inactive substance)
What is it?
Polyethylene glycol, referred to as PEG, is used as an inactive ingredient in the pharmaceutical industry as a solvent, plasticizer, surfactant, ointments, and suppository base, and tablet and capsule lubricant. PEG has low toxicity with systemic absorption less than 0.5%.
PEGylation occurs when PEGs are attached to various protein medications, allowing for greater solubility for certain drugs. Examples of PEGylated medications include PEG-interferon alpha (Pegintron) and PEG-filgrastim (Neulasta). PEG is also available as a bowel prep for colonoscopy procedures and as a laxative.
PEG 400 indicates the average molecular weight of the specific PEG at 400. PEG 3350 is a laxative available over-the-counter by the name of Miralax. In this case, PEG is considered an "active" ingredient, even though systemic absorption is less than 0.5%.
 Dave RH. Overview of pharmaceutical excipients used in tablets and capsules. Drug Topics (online). Advanstar. 10/24/2008 http://drugtopics.modernmedicine.com/drugtopics/Top+News/Overview-of-pharmaceutical-excipients-used-in-tabl/ArticleStandard/Article/detail/561047. Accessed 08/19/2011
Top Medications with this excipient
- Aleve naproxen sodium 220 mg ()
- Amoxicillin Trihydrate 875 mg ()
- Benzphetamine Hydrochloride 50 mg ()
- Bosulif 100 mg ()
- Bupropion Hydrochloride Extended-Release (SR) 150 mg ()
- Cetirizine Hydrochloride 10 mg ()
- Donepezil Hydrochloride 5 mg ()
- Hydroxychloroquine Sulfate 200 mg ()
- Hydroxyzine Hydrochloride 10 mg ()
- Hydroxyzine Hydrochloride 25 mg ()
- Hydroxyzine Hydrochloride 50 mg ()
- Janumet XR metformin extended-release 1000 mg and sitagliptin 100 mg ()
- Juvisync simvastatin 20 mg / sitagliptin 50 mg ()
- Keppra XR 500 mg ()
- Levetiracetam 750 mg ()
- Levetiracetam 500 mg ()
- Loryna drospirenone 3 mg / ethinyl estradiol 0.02 mg ()
- Losartan Potassium 50 mg ()
- Montelukast Sodium 10 mg (base) ()
- Wera ethinyl estradiol 0.035 mg / norethindrone 0.5 mg ()